Physician profile
Dong Kim
NPI 1255626495
$3,604.46
in general payments reported to CMS, 2019-2025
42 companies · $178 in 2025
The $178 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $553 · 2020: $109 · 2021: $1,551 · 2022: $584 · 2023: $302 · 2024: $328 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2021 | |
| Smith+Nephew, INC. | $237.40 | 2019-2023 | Grafix Pl |
| Osteomed LLC | $196.57 | 2019 | |
| Organogenesis INC. | $176.08 | 2021-2023 | Puraply |
| Biocomposites INC | $159.06 | 2024-2025 | Stimulan |
| Paratek Pharmaceuticals, INC. | $139.97 | 2022-2024 | Nuzyra |
| Stability Biologics, LLC | $126.86 | 2022 | |
| Horizon Therapeutics Plc | $120.49 | 2020-2023 | Krystexxa |
| Melinta Therapeutics, LLC | $115.91 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $115.84 | 2019 | |
| Vaporox, INC. | $91.72 | 2024 | Vht-200 Wound Treatment System |
| Urgo Medical North America, LLC | $85.80 | 2025 | Urgok2 |
| Novastep INC. | $65.09 | 2022-2025 | Nexis |
| Integra Lifesciences Corporation | $61.19 | 2021-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Misonix INC | $53.02 | 2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dong Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.